Patents
Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
12/2003
12/31/2003WO2004000970A1 Color tunable photoluminescent blends
12/31/2003WO2004000807A1 Cannabinoid receptor agonists
12/31/2003WO2004000789A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003WO2004000783A1 Aminoalkylphenols, methods of using and making the same
12/31/2003WO2003088959A3 Treatment of parkinson's disease with cyclooxygenase-2 (cox 2) inhibitor(s)
12/31/2003WO2003063576A3 Arylsulfonamidobenzylic compounds
12/31/2003CN1464871A Compound for organic el element and organic el element
12/31/2003CA2488972A1 Amide linker peroxisome proliferator activated receptor modulators
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/30/2003US6670486 Process for racemization
12/30/2003US6670485 Vision disorders
12/30/2003US6670473 Inhibitors of nitric oxide synthase (nos)
12/30/2003US6670385 α-phenyl-βketosulfone
12/30/2003US6670358 Substituted thioacetamides
12/30/2003US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen
12/25/2003US20030236438 Enantioselective 1,4-addition of aromatic nucleophiles to alpha,beta-unsaturated aldehydes using chiral organic catalysts
12/25/2003US20030236403 Certain substituted 1-aryl-3-piperazine-1'-yl propanones
12/25/2003US20030236297 Immunosuppressants; autoimmune diseases
12/25/2003US20030236294 Anticancer agents
12/25/2003US20030236280 Aminotetralin-derived urea modulators of vanilloid VR1 receptor
12/25/2003US20030236253 Gabapentin; antiepileptic agents, analgesics
12/25/2003US20030236232 Novel spla2 inhibitors
12/25/2003US20030235779 Photoacid generating compounds, chemically amplified positive resist materials, and pattern forming method
12/24/2003WO2003106445A1 Compounds and methods for controlling bacterial virulence
12/24/2003WO2003106405A1 Aspartyl protease inhibitors
12/24/2003WO2003106402A1 2-naphtamide derivatives
12/24/2003WO2003091675A3 Ultrasonic doppler effect speed measurement
12/24/2003WO2003084916A3 Compounds that modulate ppar activity and methods for their preparation
12/24/2003WO2003068224A3 Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases
12/24/2003WO2003067332A3 Sulfonate derivatives and the use therof as latent acids
12/24/2003WO2003042135A3 P-chiral phospholanes and phosphocyclic compounds and their use in asymmetric catalytic reactions
12/24/2003WO2003037886A3 Heteroaromatic carboxamide derivatives for the treatment of inflammation
12/24/2003WO2002028829A3 Peptide deformylase inhibitors
12/24/2003CN1463263A Method to inhibit ethylene responses in plants
12/24/2003CN1131868C 作为药物的三环△3-哌啶 As a tricyclic drug △ 3- piperidine
12/24/2003CA2489286A1 2-naphtamide derivatives
12/24/2003CA2489095A1 Aspartyl protease inhibitors
12/23/2003US6667404 Retroviral protease inhibiting compounds
12/23/2003US6667342 Benzenesulfonamide-derivatives and their use as medicaments
12/23/2003US6667336 Phenyl-thienyl-prop-1-en-3-yl-sarcosine derivatives; nontoxic; neurological and neuropsychiatric disorders; glycine transporter sequestering
12/23/2003CA2233178C (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/18/2003WO2003104219A1 Nf-kb inhibitors
12/18/2003WO2003104218A1 Nf-:b inhibitors
12/18/2003WO2003104217A2 Prodrugs of excitatory amino acids
12/18/2003WO2003103599A2 Caspase-1 inhibitors and methods for their use
12/18/2003WO2003074467A3 Urea derivatives as hiv aspartyl protease inhibitors
12/18/2003WO2003032072A3 Crosslinkable monomers for novel nonlinear optical polymers
12/18/2003WO2003027234A3 Small organic molecule regulators of cell proliferation
12/18/2003US20030232996 Regioselective synthesis of 3,4-di{(carboclyl or heterocyclyl)thiophenes
12/18/2003US20030232891 For therapy of pain
12/18/2003US20030232877 1,3-Bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
12/18/2003US20030232863 Cathepsin cysteine protease inhibitors
12/18/2003US20030232859 Antiinflammatory agents; for treatment of rheumatoid arthritis and multiple sclerosis
12/18/2003US20030232841 Amides such as 5-(2-(4-methylpiperazin-1-yl)-phenyl)-furan-2-carboxylic acid 4-chlorobenzylamide, used as antidepressants and for prophylaxis of headaches
12/18/2003US20030232830 Non-covalent inhibitors of AmpC beta-lactamase
12/18/2003US20030232808 Sulfonyl derivatives
12/18/2003US20030232807 Dietetic agents
12/18/2003US20030232805 Administering a dual serotonin/norepinephrine reuptake inhibitor or a triple monoamine reuptake inhibitor for serotonin/noradrenaline/ dopamine
12/18/2003US20030232804 Glycinamides as factor Xa inhibitors
12/17/2003EP1370548A1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same
12/17/2003EP1370546A2 Novel amines as histamine-3 receptor ligands and their therapeutic applications
12/17/2003EP1370542A1 Bicyclic guanidine derivatives and therapeutic uses thereof
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370520A1 Aryl and biaryl compounds having mch modulatory activity
12/17/2003EP1370519A1 Synthetic excitatory amino acids
12/17/2003EP1370510A2 Hiv integrase inhibitors
12/17/2003EP1370255A2 Cdc25 phosphatase inhibitors
12/17/2003EP1206467B1 N-heterocyclic derivatives as nos inhibitors
12/17/2003EP1100775B1 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
12/17/2003EP1093456B1 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
12/17/2003EP1051392B1 Adamantanecarboximidamide derivatives and their use as nmda antagonists
12/17/2003EP1000047B1 1-(n-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of the phenyl ring
12/17/2003CN1462303A Double-spiro organic compounds and electric-field luminescent devices
12/17/2003CN1462271A 3-hydroxymethylbenzo [b] thiphene derivatives and process for their preparation
12/17/2003CN1462185A Improved transdermal therapeutic system for treatment of Parkinson's disese
12/17/2003CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors
12/17/2003CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides
12/17/2003CN1131202C Calcium receptor-active compounds
12/16/2003US6664410 Solid phase nitrile synthesis
12/16/2003US6664258 Spirocyclic dopamine receptor subtype ligands
12/16/2003US6664022 Photoacid generators and photoresists comprising same
12/11/2003WO2003101979A1 Anthelmintic and insecticidal thiophene derivatives
12/11/2003WO2003101978A1 Phenyl-thiophene type vitamin d receptor modulators
12/11/2003WO2003101382A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
12/11/2003WO2003101381A2 1,2 diamido cycloalkyl sodium channel blockers
12/11/2003WO2003048144A3 Method for monosulphonylation of an aminobenzofuran compound
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2002100825A3 Anthranilic acid amides with a heteroarylsulfonyl side chain, and use thereof as antiarrhythmic active substances
12/11/2003WO2002100802A3 Fluorous triphase and other multiphase systems
12/11/2003WO2002092552A3 Benzamidoacetonitriles and their use as antiparasitics
12/11/2003WO2002089791A3 Acne treatment with lipooxigenase inhibitors
12/11/2003US20030229228 Plant safening agents; fungicides
12/11/2003US20030229127 Heterocyclic sulfonamide inhibitors of beta amyloid production
12/11/2003US20030229126 N-substituted benzothiophenesulfonamide derivatives
12/11/2003US20030229121 Antihistamines, antiallergens, skin disorders, antiinflammatory agents
12/11/2003US20030229102 Sulfonamide derivatives
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229073 Tricyclic compounds and method of treating herpes virus
12/11/2003US20030229066 Central nervous system diosrders; psychological disorders
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections